关注
Dr. Maximilian Schons
Dr. Maximilian Schons
Alvea.bio
在 mxschons.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry
MM Rüthrich, C Giessen-Jung, S Borgmann, AY Classen, S Dolff, ...
Annals of hematology 100, 383-393, 2021
1822021
First results of the “lean European open survey on SARS-CoV-2-infected patients (LEOSS)”
CEM Jakob, S Borgmann, F Duygu, U Behrends, M Hower, U Merle, ...
Infection 49, 63-73, 2021
722021
The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics
M Schons, L Pilgram, JP Reese, M Stecher, G Anton, KS Appel, T Bahmer, ...
European Journal of Epidemiology 37 (8), 849-870, 2022
372022
Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population …
A Horn, L Krist, W Lieb, FA Montellano, M Kohls, K Haas, G Gelbrich, ...
Infection 49, 1277-1287, 2021
312021
Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning
CEM Jakob, UM Mahajan, M Oswald, M Stecher, M Schons, J Mayerle, ...
Infection, 1-12, 2021
232021
All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort
MJ Schons, A Caliebe, CD Spinner, AY Classen, L Pilgram, MM Ruethrich, ...
Infection, 1-14, 2022
142022
The COVID-19 pandemic as an opportunity and challenge for registries in health services research: lessons learned from the lean european open survey on sARS-CoV-2 infected …
L Pilgram, M Schons, CEM Jakob, AY Classen, B Franke, L Tscharntke, ...
Gesundheitswesen (Bundesverband der Arzte des Offentlichen …, 2021
92021
SARS-CoV-2/COVID-19 and neuromuscular disorders: An overview of the DGN (German Neurological Society) Commission on Motor Neuron and Neuromuscular Diseases
B Schoser, P Baum, M Boentert, KU Dillmann, A Emmer, S Knauss, ...
DGNeurologie 3, 310-320, 2020
62020
Development and validation of a simplified risk score for the prediction of critical COVID19 illness in newly diagnosed patients
S Werfel, CEM Jakob, S Borgmann, J Schneider, C Spinner, M Schons, ...
Journal of medical virology 93 (12), 6703-6713, 2021
52021
Die COVID-19 Pandemie als Herausforderung und Chance für Register in der Versorgungsforschung: Erfahrungen aus Lean European Open Survey on SARS-CoV-2 Infected Patients (LEOSS)
L Pilgram, M Schons, CEM Jakob, AY Claßen, B Franke, L Tscharntke, ...
Das Gesundheitswesen 83 (S 01), S45-S53, 2021
52021
Entwicklung und Validierung potenzieller Strukturindikatoren zur Evaluierung des klinisch-infektiologischen Versorgungsangebots in deutschen Krankenhäusern während der COVID-19 …
L Tscharntke, M Stecher, AY Classen, N Jung, L Eberwein, A Friedrichs, ...
Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 176, 12-21, 2023
12023
COVID-19 in cancer patients: clinical characteristics and outcome-a first analysis of the LEOSS registry
MM Ruethrich, G Kniele, L Tometten, S Borgmann, J Schneider, S Dolff, ...
12020
Auswirkungen der Antibiotikatherapie auf klinische Endpunkte bei COVID-19 Patient: innen auf der Grundlage einer Analyse der Daten der Lean European Open Survey on SARS-CoV-2 …
M Schons
Universität zu Köln, 2023
2023
Development and validation of potential structure indicators for clinical infectious disease (ID) care in German hospitals during the COVID-19 pandemic
L Tscharntke, M Stecher, AY Classen, N Jung, L Eberwein, A Friedrichs, ...
Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen 176, 12-21, 2023
2023
Development and validation of a simplified risk score for the prediction of critical COVID-19 illness in newly diagnosed patients (vol 93, pg 6703, 2021)
S Werfel, CEM Jakob, S Borgmann, J Schneider, C Spinner, M Schons, ...
JOURNAL OF MEDICAL VIROLOGY, 2022
2022
Role and benefits of infectious diseases (ID) specialists in the COVID-19 pandemics
L Tscharntke, N Jung, S Rieg, C Spinner, F Hanses, S Borgmann, K Wille, ...
INFECTION 49 (SUPPL 1), S36-S36, 2021
2021
Erratum to: SARS-CoV-2/COVID-19 and neuromuscular disorders: An overview of the DGN (German Neurological Society) Commission on Motor Neuron and Neuromuscular Diseases
B Schoser, P Baum, M Boentert, K Dillmann, A Emmer, S Knauss, ...
DGNeurologie 3, 472-472, 2020
2020
Erratum zu: SARS-CoV-2/COVID-19 und neuromuskuläre Erkrankungen: Bestandsaufnahme der DGN (Deutsche Gesellschaft für Neurologie) Kommission Motoneuron-und neuromuskuläre …
B Schoser, P Baum, M Boentert, K Dillmann, A Emmer, S Knauss, ...
DGNeurologie 3 (5), 472, 2020
2020
Safety and Immunogenicity of a DNA SARS-CoV-2 Vaccine (Alveavax-V1. 2): Results of a First-in-Human, Open-Label, Active-Controlled, Randomized Dose-Finding Study of Intradermal …
M Schons, T Odendahl, J Smith, K Fish, A Franz, M Saskena, ...
系统目前无法执行此操作,请稍后再试。
文章 1–19